ATE484290T1 - Peptid mit antitumoraler wirkung - Google Patents
Peptid mit antitumoraler wirkungInfo
- Publication number
- ATE484290T1 ATE484290T1 AT05823400T AT05823400T ATE484290T1 AT E484290 T1 ATE484290 T1 AT E484290T1 AT 05823400 T AT05823400 T AT 05823400T AT 05823400 T AT05823400 T AT 05823400T AT E484290 T1 ATE484290 T1 AT E484290T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- peptides
- tumoral effect
- analogs
- fragments
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62622004P | 2004-11-08 | 2004-11-08 | |
| PCT/US2005/040078 WO2006052775A2 (en) | 2004-11-08 | 2005-11-04 | Peptide anti - tumor agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE484290T1 true ATE484290T1 (de) | 2010-10-15 |
Family
ID=36337037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05823400T ATE484290T1 (de) | 2004-11-08 | 2005-11-04 | Peptid mit antitumoraler wirkung |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7173110B2 (de) |
| EP (1) | EP1812035B1 (de) |
| JP (2) | JP5138378B2 (de) |
| AT (1) | ATE484290T1 (de) |
| CA (1) | CA2584805C (de) |
| DE (1) | DE602005024161D1 (de) |
| WO (1) | WO2006052775A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7173110B2 (en) * | 2004-11-08 | 2007-02-06 | New York University | Peptide anti-tumor agent |
| JP5690810B2 (ja) * | 2009-04-13 | 2015-03-25 | イーエルシー マネージメント エルエルシー | メチオニンスルホキシドペプチド、組成物および使用方法 |
| MX346043B (es) * | 2012-01-06 | 2017-03-03 | Novus Int Inc | Tensioactivos basados en sulfoxido. |
| RU2620170C1 (ru) * | 2016-08-02 | 2017-05-23 | Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России | Применение катионных пептидов для индукции гибели клеток меланомы кожи человека |
| US10584306B2 (en) | 2017-08-11 | 2020-03-10 | Board Of Regents Of The University Of Oklahoma | Surfactant microemulsions |
| CA3126917A1 (en) * | 2019-01-14 | 2020-07-23 | New York University | Cyclic peptide dimers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4307082A (en) | 1979-07-10 | 1981-12-22 | New York University | Method for the extraction of a factor that mediates contact inhibition of cell growth |
| US4530784A (en) | 1983-08-19 | 1985-07-23 | New York University | Large scale extraction process for contact inhibitory factor |
| DE3841763A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
| US5942492A (en) * | 1996-11-12 | 1999-08-24 | Angstrom Pharmaceuticals, Inc. | Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| AU2003216388A1 (en) * | 2002-02-22 | 2003-09-09 | New York University | Biological inhibitions induced by contact inhibitory factor |
| JP2004083427A (ja) * | 2002-08-23 | 2004-03-18 | Microbial Chem Res Found | 環状ヘキサペプチド及びプロテアソーム阻害剤 |
| US7173110B2 (en) * | 2004-11-08 | 2007-02-06 | New York University | Peptide anti-tumor agent |
-
2005
- 2005-10-31 US US11/264,684 patent/US7173110B2/en not_active Expired - Lifetime
- 2005-11-04 WO PCT/US2005/040078 patent/WO2006052775A2/en not_active Ceased
- 2005-11-04 EP EP05823400A patent/EP1812035B1/de not_active Expired - Lifetime
- 2005-11-04 DE DE602005024161T patent/DE602005024161D1/de not_active Expired - Lifetime
- 2005-11-04 AT AT05823400T patent/ATE484290T1/de not_active IP Right Cessation
- 2005-11-04 CA CA2584805A patent/CA2584805C/en not_active Expired - Fee Related
- 2005-11-04 JP JP2007540087A patent/JP5138378B2/ja not_active Expired - Fee Related
-
2006
- 2006-12-22 US US11/615,723 patent/US7691964B2/en active Active
-
2009
- 2009-12-28 US US12/647,899 patent/US8003598B2/en not_active Expired - Lifetime
-
2012
- 2012-08-17 JP JP2012181004A patent/JP2013005804A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20070123454A1 (en) | 2007-05-31 |
| DE602005024161D1 (de) | 2010-11-25 |
| CA2584805A1 (en) | 2006-05-18 |
| EP1812035A4 (de) | 2008-04-16 |
| US20060258573A1 (en) | 2006-11-16 |
| US7173110B2 (en) | 2007-02-06 |
| WO2006052775A3 (en) | 2006-07-20 |
| CA2584805C (en) | 2014-01-28 |
| US7691964B2 (en) | 2010-04-06 |
| US8003598B2 (en) | 2011-08-23 |
| US20100305044A1 (en) | 2010-12-02 |
| EP1812035A2 (de) | 2007-08-01 |
| WO2006052775A2 (en) | 2006-05-18 |
| JP2008518622A (ja) | 2008-06-05 |
| JP2013005804A (ja) | 2013-01-10 |
| EP1812035B1 (de) | 2010-10-13 |
| JP5138378B2 (ja) | 2013-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118849T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| NZ534919A (en) | Bioactive keratin peptides | |
| NO20044039L (no) | Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider. | |
| ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
| BR112012011332A2 (pt) | agentes direcionados para gadd45beta | |
| CY1107051T1 (el) | Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους | |
| CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
| CY1105616T1 (el) | ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1 | |
| NZ576467A (en) | Smoothened polypeptides and methods of use | |
| EA200500871A1 (ru) | Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение | |
| FR2835528B1 (fr) | Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique | |
| DE602004014145D1 (de) | Von rasgap-abgeleitetes peptid zur gezielten tötung von krebszellen | |
| EA200702656A1 (ru) | Составы, содержащие пептиды, стимулирующие рецептор эритропоэтина, и их применение | |
| NO20062198L (no) | Bradykinin B1 reseptorantagonister | |
| CY1114724T1 (el) | Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων | |
| HRP20050024A2 (en) | Pegylated t20 polypeptide | |
| ATE484290T1 (de) | Peptid mit antitumoraler wirkung | |
| ATE474589T1 (de) | Angiogene peptide und ihre verwendungen | |
| DE60229867D1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
| UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение | |
| AU2003260452A8 (en) | Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells | |
| WO2006122162A3 (en) | Use of peptides derived from the growth factor amp-18 for the treatment of mucositis | |
| ES2164011B1 (es) | Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos. | |
| ATE420890T1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide | |
| TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |